52 Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment

IF 5.4 2区医学 Q1 RESPIRATORY SYSTEM

Journal of Cystic Fibrosis Pub Date : 2024-09-01 DOI:10.1016/S1569-1993(24)00895-6

T. Bryrup, D. Faurholt-Jepsen, M. Skov, T. Katzenstein, I. Mathiesen, J. Helweg-Larsen, H. Johansen, T. Qvist, T. Pressler

引用次数: 0

查看原文本刊更多论文

52 elexacaftor/tezacaftor/ivacaftor治疗前后的特异性铜绿假单胞菌IgG水平

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cystic Fibrosis 医学-呼吸系统

CiteScore

10.10

自引率

13.50%

发文量

1361

审稿时长

50 days

期刊介绍： The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society. The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. The journal also publishes news and articles concerning the activities and policies of the ECFS as well as those of other societies related the ECFS.